SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-025087
Filing Date
2019-12-02
Accepted
2019-12-02 13:17:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G sc13g1219a4etfmanager_corbus.htm SC 13G/A 38500
  Complete submission text file 0001213900-19-025087.txt   40070
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Subject) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88716 | Film No.: 191262753
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901
Business Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901 908-897-0513
ETF MANAGERS GROUP, LLC (Filed by) CIK: 0001645173 (see all company filings)

IRS No.: 383938178 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A